Literature DB >> 2777790

Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein.

K Cseh1, B Beutler.   

Abstract

Cachectin/tumor necrosis factor is initially synthesized as a 26 kilodalton prohormone. This molecule is 76 (human) or 79 (mouse) amino acids longer than the mature protein, as a result of additional residues present at the amino terminus. A short hydrophobic stretch of amino acids serves to anchor the prohormone in lipid bilayers; the mature protein, as well as a partially processed form of the hormone, are secreted after cleavage of the propeptide. We have analyzed the cleavage of the murine propeptide as it occurs in RAW 264.7 cells and now report that scission occurs at a site within the propeptide fragment, 10 residues before the amino-terminal leucine of the mature protein. This incompletely processed form of the molecule also begins with a leucine residue. Although secreted as a soluble product, it is biologically inactive in the L-929 cell cytotoxicity assay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777790

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Authors:  A Poltorak; P Ricciardi-Castagnoli; S Citterio; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Sequence of the tumor necrosis factor/cachectin (TNF) gene from Peromyscus leucopus (family Cricetidae).

Authors:  M D Crew; M E Filipowsky
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 4.  Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.

Authors:  P F Piguet
Journal:  Springer Semin Immunopathol       Date:  1992

5.  Isolation and partial characterization of the structures of fibroblast activating factor-related proteins from U937 cells.

Authors:  J Demeter; D Medzihradszky; H Kha; E J Goetzl; C W Turck
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

6.  Constitutive synthesis of tumor necrosis factor in the thymus.

Authors:  B P Giroir; T Brown; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  Analysis of tumor necrosis factor promoter responses to ultraviolet light.

Authors:  F Bazzoni; V Kruys; A Shakhov; C V Jongeneel; B Beutler
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.

Authors:  B Beutler; T Brown
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

9.  The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

Authors:  B P Giroir; J H Johnson; T Brown; G L Allen; B Beutler
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

Authors:  Y Harel; M Silva; B Giroir; A Weinberg; T B Cleary; B Beutler
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.